Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial.

Dahdaleh FS, Sherman SK, Poli EC, Vigneswaran J, Polite BN, Sharma MR, Catenacci DV, Maron SB, Turaga KK.

Surgery. 2018 Oct 5. pii: S0039-6060(18)30391-X. doi: 10.1016/j.surg.2018.06.044. [Epub ahead of print]


Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma.

Maron SB, Alpert L, Kwak HA, Lomnicki S, Chase L, Xu D, O'Day E, Nagy RJ, Lanman RB, Cecchi F, Hembrough T, Schrock A, Hart J, Xiao SY, Setia N, Catenacci DVT.

Cancer Discov. 2018 Jun;8(6):696-713. doi: 10.1158/2159-8290.CD-17-1260. Epub 2018 Feb 15.


Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.

Joshi SS, Maron SB, Catenacci DV.

Future Oncol. 2018 Feb;14(5):417-430. doi: 10.2217/fon-2017-0436. Epub 2017 Nov 2. Review.


Update on Gastroesophageal Adenocarcinoma Targeted Therapies.

Maron SB, Catenacci DVT.

Hematol Oncol Clin North Am. 2017 Jun;31(3):511-527. doi: 10.1016/j.hoc.2017.01.009. Review.


Novel Targeted Therapies for Esophagogastric Cancer.

Maron SB, Catenacci DV.

Surg Oncol Clin N Am. 2017 Apr;26(2):293-312. doi: 10.1016/j.soc.2016.10.002. Review.


Recombination and positive selection contributed to the evolution of Listeria monocytogenes lineages III and IV, two distinct and well supported uncommon L. monocytogenes lineages.

Tsai YH, Maron SB, McGann P, Nightingale KK, Wiedmann M, Orsi RH.

Infect Genet Evol. 2011 Dec;11(8):1881-90. doi: 10.1016/j.meegid.2011.08.001. Epub 2011 Aug 11.


Lineage specific recombination and positive selection in coding and intragenic regions contributed to evolution of the main Listeria monocytogenes virulence gene cluster.

Orsi RH, Maron SB, Nightingale KK, Jerome M, Tabor H, Wiedmann M.

Infect Genet Evol. 2008 Sep;8(5):566-76. doi: 10.1016/j.meegid.2008.04.006. Epub 2008 Apr 20.

Supplemental Content

Loading ...
Support Center